The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...

Pregnant women who are incarcerated will move into the facility next week. For now, only women with 18 months or less to ...

Donald Trump’s tariff war is too much for his otherwise steadfast ally Senator Ron Johnson, who compared the decision to ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

So, again, I just can't predict where this all goes, but I'm concerned. I don't know what else I can really say,” Johnson said ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the stock has risen by around just 3%. This is not the type of investment ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

NEW YORK – William E. Leuchtenburg, a prize-winning historian widely admired for his authoritative writings on the U.S.

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.